Corrigendum to “SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy”

Detalles Bibliográficos
Autores principales: Choy, Edwin, Ballman, Karla, Chen, James, Dickson, Mark A., Chugh, Rashmi, George, Suzanne, Okuno, Scott, Pollock, Raphael, Patel, Rajiv M., Hoering, Antje, Patel, Shreyaskumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732588/
https://www.ncbi.nlm.nih.gov/pubmed/31534435
http://dx.doi.org/10.1155/2019/7608743

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732588/
https://www.ncbi.nlm.nih.gov/pubmed/31534435
http://dx.doi.org/10.1155/2019/7608743

Ejemplares similares